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Abstract 
A potential standard method for measuring the relative dissolution rate to estimate the 
resorbability of calcium-phosphate-based ceramics is proposed. Tricalcium phosphate 
(TCP), magnesium-substituted TCP (MgTCP) and zinc-substituted TCP (ZnTCP) were 
dissolved in a buffer solution free of calcium and phosphate ions at pH 4.0, 5.5 or 7.3 at 
nine research centers. Relative values of the initial dissolution rate (relative dissolution 
rates) were in good agreement among the centers. The relative dissolution rate 
coincided with the relative volume of resorption pits of ZnTCP in vitro. The relative 
dissolution rate coincided with the relative resorbed volume in vivo in the case of 
comparison between microporous MgTCPs with different Mg contents and similar 
porosity. However, the relative dissolution rate was in poor agreement with the relative 
resorbed volume in vivo in the case of comparison between microporous TCP and 
MgTCP due to the superimposition of the Mg-mediated decrease in TCP solubility on 
the Mg-mediated increase in the amount of resorption. An unambiguous conclusion 
could not be made as to whether the relative dissolution rate is predictive of the relative 
resorbed volume in vivo in the case of comparison between TCPs with different porosity. 
The relative dissolution rate may be useful for predicting the relative amount of 
resorption for calcium-phosphate-based ceramics having different solubility under the 
condition that the differences in the materials compared have little impact on the 
resorption process such as the number and activity of resorbing cells. 
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1. Introduction 
The evaluation and subsequent optimization of the resorbability of calcium 
phosphate are crucial in the use of resorbable calcium phosphates. Resorbable calcium 
phosphates include β-tricalcium phosphate (β-TCP), α-tricalcium phosphate, 
carbonated hydroxyapatite, low-crystalline hydroxyapatite, and a certain range of 
biphasic hydroxyapatite and β-TCP. These calcium phosphates are not only 
osteoconductive but are also gradually resorbed in a long period of time after 
implantation [1-10]. The rate of resorption needs to be optimized depending on the 
intended purpose and be balanced with bone tissue regeneration for successful clinical 
treatments. Moreover, recent findings suggest that the optimized resorption or 
degradation of calcium phosphates itself can enhance bone tissue regeneration through 
an immunomodulatory action [11-14].  
Possible alternatives to animal testing for evaluating the resorbability include 
cell-based assay, simulation and dissolution tests. Cell-based resorption assay uses a 
variety of resorbing cells including primary and tumor osteoclasts, differentiated 
osteoclasts and monocyte/macrophage cell lines [15, 16]. A limitation of cell-based 
assay is that the assay requires a flat surface for evaluating resorption lacuna or pits. 
Thus, it is difficult to evaluate the resorbability of porous bodies and granules. 
Simulation is an alternative to animal testing that is applicable to porous bodies. Recent 
simulations have demonstrated an excellent correlation with in vivo resorption data for 
macroporous β-TCP [17, 18]. The simulation is intrinsically based on the paradigm that 
only osteoclasts and/or macrophages in the vicinity of blood vessels can survive and 
resorb the surface of the pores. A dissolution test is potentially a chemical alternative to 
animal testing for the evaluation of resorption because the resorption of calcium 
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phosphate is substantially a process of cell-mediated dissolution in acidic fluids inside 
the resorption lacunae underneath osteoclasts or in the phagolysosome of phagocytic 
cells. The values of the acidic pH have been reported to be 3.9–6.0 [19-23].  
Different dissolution tests of calcium phosphates have been carried out under 
various conditions using either continuous or discontinuous measurement techniques. 
The continuous measurement techniques include the constant composition method 
[24-26], the constant pH method [27] and other methods using electrodes [28]. The 
discontinuous measurement techniques include pharmacopoeia methods such as the BP 
(British Pharmacopoeia) and USP (United States Pharmacopeia) methods and other 
intermittent sampling-and-analysis methods [29, 30]. The pH values ranged from ≈3 to 
7.4 in these dissolution tests. The dissolution tests did not necessarily aim to predict in 
vivo resorption. However, some dissolution tests of calcium phosphates have been found 
to be predictive of their resorption behavior in vivo [31]. 
On the basis of the background described above, a dissolution test method to predict 
the resorption of calcium phosphates is proposed as a potential standard method in the 
present study. The efficacy and limitations of the method were evaluated by round-robin 
tests as well as comparison with in vitro and in vivo resorption studies.  
 
2. Materials and methods 
2.1. Materials 
Specimens of sintered polycrystalline TCP, magnesium-containing TCP (MgTCP) and 
zinc-containing TCP (ZnTCP) were used (Table 1). The TCP25 and TCP35 were 100% 
macroporous bodies of TCP with intended relative densities of 25% and 35%, 
respectively. The TCP60, TCP70 and TCP90 were 100% microporous bodies of TCP 
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with intended relative densities of 60, 70 and 90%, respectively. The 1.0MgTCP, 
1.7MgTCP and 3.4MgTCP were 100% microporous bodies of MgTCP containing 1.0, 
1.7 and 3.4 mol% of Mg, respectively, with an intended relative density of 60%. 
0.5ZnTCP and 1.0ZnTCP were 100% microporous bodies of ZnTCP containing 0.5 and 
1.0 mol% of Zn, respectively, with an intended relative density of 90%. Scanning 
electron microscopy (SEM) images of the specimens are shown in the supporting data 
(Fig. S1). The specimens have block, cylinder and disk shapes with dimensions as listed 
in Table 1. The TCP25 and TCP35 had a block shape and used in the dissolution study. 
The TCP60, TCP70, 1.0MgTCP, 1.7MgTCP and 3.4MgTCP had a cylinder shape and 
used in the dissolution and in vivo resorption studies. The TCP90, 0.5ZnTCP and 
1.0ZnTCP had a disk shape and used in the dissolution and osteoclastic resorption 
studies. The cylinder specimens for the in vivo resorption study had 1-mm-thick 
biphasic (TCP and hydroxyapatite) portions with a Ca/P molar ratio of 1.60 at both ends. 
The biphasic portion was microscopically non-resorbable in the cortical region in the 
present animal model (Fig. S2). The biphasic portion was used to define the base line of 
zero resorption when measuring the resorbed volume in the in vivo study. All specimens 
were prepared by sintering in the temperature range from 1030 to 1100 ˚C depending 
on the chemistry and intended relative density. All the specimens except for the 
macroporous TCP25 and TCP35 were prepared in the research center A. The 
macroporous specimens were prepared by Covalent Materials Co., Japan, then subjected 
to quality inspection at research center A.  
 
2.2. Interlaboratory dissolution tests 
Interlaboratory dissolution tests were performed at nine research centers (A-I; Table 2). 
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The protocol for dissolution tests is described in supporting data. Briefly, the specimens 
were dissolved in either 0.05 M potassium hydrogen phthalate buffer solution at pH 4.0, 
0.08 M acetic acid-sodium acetate buffer solution at pH 5.5 or 0.05 M Tris-HCl buffer 
solution at pH 7.3 while stirring the buffer solutions. The dissolution temperature was 
25 ˚C except in the pharmacopoeia method, where it was 37 ˚C (A-5 in Table 2). The 
dissolution period was 5, 18, 30, 180 or 300 min, where 30 min was adopted in most 
cases. The volumes of the solutions were from 35 to 100 mL except in the 
pharmacopoeia method, where it was 200 mL. The calcium concentration was measured 
continuously or intermittently. The continuous measurement was made using calcium 
ion-selective electrodes. The intermittent measurement was made by collecting 1 mL of 
solution at intervals of 3 or 5 min except in the pharmacopoeia method, in which 5 mL 
was collected at intervals of 60 min. The collected solution was analyzed for calcium 
using atomic absorption spectroscopy (AAS), inductively coupled plasma atomic 
emission spectrometry (ICP) or inductively coupled plasma mass spectrometry 
(ICP-MS). Three to ten samples of TCP,  MgTCPs and ZnTCPs were subjected to the 
dissolution test. The data of calcium concentration at the end of the dissolution period 
were converted to the dissolved amount (µmol) of TCP, MgTCPs or ZnTCPs on the 
assumption that the dissolution proceeded congruently. The dissolved amount divided 
by the dissolution period gave the dissolution rate (µmol/s). The dissolution rate was 
averaged over every specimen subjected to the dissolution test (n=3-10). The average 
dissolution rate was divided by that of TCP60, TCP25, 1.0MgTCP or TCP90 to obtain 
the relative dissolution rate. The relative dissolution rates were used to characterize 
dissolution behaviors and for comparison with relative amount of resorption in vitro and 
in vivo. 
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2.3. Osteoclastic resorption 
 
Previous data of volume of osteoclastic resorption pits measured at research center A on 
the TCP90, 0.5ZnTCP and 1.0ZnTCP disks (Specimens 13-15, respectively) with 
relative densities of 91-93% was analyzed – The previous paper reported incorrect 
relative densities (67-83%) for the disks – [32]. Briefly, the osteoclasts were isolated 
from unfractionated bone cells in the bone of 10-day-old Japanese white rabbits. 
Between 1×104 and 3×104 mature osteoclasts were obtained from one rabbit. More 
than 90% of the cells obtained were tartrate-resistant acid phosphatase (TRAP)-positive 
and multinucleate (three or more nuclei). The osteoclasts were seeded on the TCP and 
ZnTCP disks previously placed in each well of a 12-well plate and cultured for 2 hours 
at 37 °C to allow them to attach to the disks. After cultivation for 2 hours, 2 ml of 
α-MEM with 10% FBS and 5% L-glutamine supplemented with 100 ng/ml of 
macrophage colony-stimulation factor (M-CSF) (mouse recombinant, Calbiochem) and 
50 ng/ml of TRANCE (mouse recombinant RANK ligand, TECHNE Co.) were added 
to each well. The osteoclasts were further cultured for 24 hours at 37 °C. After 
cultivation for 24 hours, the osteoclasts were removed from the disks by sonication in a 
0.25 M NH4OH solution. All disks were then dehydrated in a graded series of ethanol 
concentrations and processed with a critical point dryer. They were subsequently coated 
with platinum in a cold sputter coater to visualize the resorption pits. The coated disks 
were examined with a color laser microscope (VK-9500, KEYENCE, Japan) equipped 
with an image analysis system (VK-9500 analyzer, KEYENCE, Japan) at a 
magnification of x50. The volumes of 30 randomly selected pits on each of the four 
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disks (120 pits in total) were measured. The pit volumes were averaged over the 120 
pits. The average pit volume of for 0.5ZnTCP and 1.0ZnTCP was divided by that of the 
TCP90 to obtain the relative pit volume. The relative pit volumes were compared with 
the relative dissolution rates of corresponding ZnTCP disks measured at research center 
C. 
 
2.4. In vivo resorption 
The in vivo resorption study was performed at research center A. Cylindrical implants of 
TCP60, TCP70, 1.0MgTCP, 1.7MgTCP and 3.4MgTCP (Specimens 8-12, respectively) 
were implanted perpendicular to the long axis of the femoral diaphysis of skeletally 
mature New Zealand White rabbits (male, 15 months old, 3.0-3.5 kg in weight) for four 
weeks. The same group of specimens was implanted bilaterally. After sacrifice, all the 
bone specimens containing the implants were subjected to undecalcified histological 
processing except for one pair of bone specimens (right and left) randomly selected 
from each group for decalcified histological processing. For undecalcified histological 
processing, the bone specimens were immersed in a 70% ethanol solution for 1 week for 
fixation. The bone specimens were stained with Villanueva Bone (VB) solution, 
embedded in methyl methacrylate (MMA), cut into two or three sections by cutting 
parallel to the long axis of the implant and ground to 50-µm-thick undecalcified sections. 
The resorption of implants was revealed by the rugged external form of the implants on 
undecalcified sections observed with a stereoscopic microscope (Fig. 1). 
 
The area of resorption lying between the rugged outline and the original outline 
was measured by image analysis (Image-Pro PLUS, Ver 6.1). From the area of 
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resorption, the apparent resorbed volume of the implant per unit lateral area of the 
implant (V) was calculated according to a method described elsewhere [33]. The 
measurement was performed on bone specimens with no femoral fracture, in-process 
implant fracture or deformation. The apparent resorbed volume per cylindrical length of 
1 mm (V1) was calculated using the following equation:  
V1 = 2πrV (mm
3), 
where r is the radius of the implant. The net amount of resorbed TCP or MgTCPs per 
cylindrical length of 1 mm (A1) was calculated using 
   A1 = DrDV1/100M (µmol), 
where Dr, D and M are the relative density of the implant, the density of TCP or 
MgTCPs and the molecular weight of TCP or MgTCPs, respectively. The V1 and A1 
were averaged over every specimen (n=8-10). The average V1 and A1 was divided by the 
average V1 and A1, respectively, of the TCP60 or 1.0MgTCP to obtain relative V1 and A1.    
The relative V1 and A1 were compared with the relative dissolution rates measured at 
research centers A-I. 
 
For decalcified histological processing, the bone specimens were fixed in 10% 
neutral-buffered formalin, decalcified, embedded in paraffin and cut into 5-µm-thick 
sections with the staining of toluidine blue and TRAP to observe the osteoclasts. The 
number of TRAP-positive cells existing less than 200 µm from the implant was 
measured on 6-16 microscopic images within the section. Thus, the average and 
standard deviation for each group are those for the 6-16 images from one rabbit. All 
animal experiments were performed under conditions approved by the Institutional 
Animal Care and Use Committee of National Institute of Advanced Industrial Science 
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and Technology (AIST) and in accordance with the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health (NIH 1996).     
 
2.5. Statistical analysis 
All statistical comparisons were conducted using Student’s t-tests. The standard 
deviations (σ) of the relative values,  	 , such as the relative dissolution rate, pit 
volume, V1 and A1 were calculated using 
    σ = − 	
	
 ∙  +  	
 ∙  
where  and  are average values for groups 0 and 1, and  and  are the 
standard deviations for groups 0 and 1, respectively. The significance level was set at p 
< 0.05. 
 
3. Results 
The dissolution curves were almost linear during the dissolution periods at pH 4.0, 
5.5 and 7.3 (Fig. 2 and Fig. S6). The calculated dissolution rates represented the slopes 
of the dissolution curves. The dissolution rate of the same specimen under the same pH 
condition varied by up to 600% depending on the research center and the dissolution 
conditions such as the solution volume (35-200 mL) and stirring speed (200-450 rpm). 
However, the relative dissolution rates, i.e., the average dissolution rates of TCP70, 
TCP25, TCP35, 1.0MgTCP, 1.7MgTCP and 3.4MgTCP relative to that of TCP60, 
varied by only up to 183% in spite of the differences in solution volumes, stirring 
speeds and even pH (4.0, 5.5 and 7.3) as shown in Figs. 3-6.  
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The relative dissolution rates had higher sensitivity to a difference in microporosity 
than to a difference in macroporosity. The relative dissolution rates of microporous 
TCP70 compared with microporous TCP60 were significantly lower than 1.0 except for 
research center G as shown in Fig. 3. However, the relative dissolution rates of 
macroporous TCP35 compared with macroporous TCP25 showed no significant 
difference (p>0.05) against 1.0 except for a condition H-2 (Fig. 4). Thus, a 10% 
difference in microporosity has a greater effect on the dissolution rate than the same 
difference in macroporosity. 
 
The relative pit volume and relative dissolution rate decreased with an increase in 
the zinc content of TCP (Fig. 7). The relative pit volume for 0.5ZnTCP compared with 
TCP90 was significantly lower than 1.0. Similarly, the relative pit volume for 1.0ZnTCP 
was significantly lower than both 1.0 and that for 0.5ZnTCP. The dissolution rates for 
0.5ZnTCP and 1.0ZnTCP compared with TCP90 were significantly lower than 1.0. The 
relative dissolution rate for 1.0ZnTCP was not significantly lower than that for 
0.5ZnTCP (p=0.066).  
The relative pit volumes agreed with the relative dissolution rates without 
significant differences for both 0.5ZnTCP and 1.0ZnTCP (p=0.33 for 0.5 ZnTCP and 
0.46 for 1.0 ZnTCP).     
 
  The apparent resorbed volume in vivo, V1, for microporous TCP60, TCP70, 
1.0MgTCP, 1.7MgTCP and 3.4MgTCP depended on the relative density and magnesium 
content. Individual V1 values for the same specimen varied by up to 268%. The average 
value of V1 was from 0.25 to 0.39 mm
3 (Fig. 8). There was no significant difference in 
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V1 between TCP60 and TCP70 (p=0.088). The TCP60 and TCP70 specimens had 
relative densities of 62 and 72%, respectively (Table 1). The MgTCP specimens, which 
had the similar relative density (65-67%) and different Mg contents, tended to have 
decreasing V1 with increasing Mg content from 1.0 to 3.4 mol% (1.0MgTCP, 1.7MgTCP 
and 3.4 MgTCP).  
 
The relative dissolution rate was in good agreement with the relative V1 but in poor 
agreement with the relative A1 in the case of the microporous TCP specimens (Fig. 3). 
The relative dissolution rates of microporous TCP70 compared with microporous 
TCP60 agreed with the relative V1 for TCP70 compared with microporous TCP60 
without significant differences (p=0.54-0.08) except for condition E-1 (p=0.03). 
However, the relative dissolution rates were significantly different from the relative A1 
under five conditions (A-4, C, D, E-1 and A-6 in Fig. 3). 
 
The relative dissolution rate coincided with the relative V1 and A1 among the 
microporous MgTCP specimens. The relative dissolution rates of 1.7MgTCP and 
3.4MgTCP compared with 1.0MgTCP were in the range from 0.88 to 0.95 and from 
0.48 to 0.61, respectively (Fig. 5). These relative dissolution rates agreed with the 
relative V1 and A1 of 1.7MgTCP and 3.4MgTCP compared with 1.0MgTCP without 
significant differences (p=0.49-0.11) (Fig. 5). However, the relative dissolution rates of 
1.0MgTCP, 1.7MgTCP and 3.4MgTCP compared with TCP60 were all significantly 
lower than the corresponding relative V1 and A1 except for condition A-3 for 1.0MgTCP 
and H-1 for 3.4MgTCP (Fig. 6). More osteoclasts were observed around the 1.0MgTCP, 
1.7MgTCP and 3.4MgTCP implants than around TCP60 implants, although the 
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differences were not significantly different (Fig. 9). 
   
4. Discussion 
In the present study, the dissolution tests were designed to test different calcium 
phosphate phases under a range of undersaturation starting at 1 and ending – for the 
lowest value – at 0.8 (see supporting data and Table S8) regardless of the specimen. In 
this range of undersaturation, the dissolution curves were almost linear, which was 
useful for defining the dissolution rates.  
 
A dissolution rate is a function of both the equilibrium solubility and kinetic factors 
such as the surface area, particle size, porosity and crystallinity. The resorption of 
calcium phosphate biomaterials depends both on their equilibrium solubility and kinetic 
factors [17, 31, 34]. Thus, we focused on measuring the dissolution rate. However, the 
dissolution rate was unacceptable as a standard index due to large interlaboratory 
differences. On the other hand, the interlaboratory differences were diminished 
efficiently by converting the dissolution rate to the relative dissolution rate. The 
interlaboratory differences in the relative dissolution rates (183% at maximum) were 
within the scattering in the V1 (268% at maximum) obtained from in vivo experiments. 
The maximum value of 183% in interlaboratory difference was obtained in spite of a 
wide range of differences in solution volumes (35-200 mL), stirring speeds (200-450 
rpm) and even pH (4.0, 5.5 and 7.3).  Note that a difference of 1.0 in pH gives a 
difference of 660% in initial dissolution rate of TCP [27]. Therefore, the relative 
dissolution rate can be a useful standard index that is used regardless of a wide range of 
differences in dissolution condition.   
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  The relative dissolution rates agreed with the relative pit volumes for ZnTCPs having 
different equilibrium solubility. The zinc incorporated in TCP decreases the equilibrium 
solubility of TCP [33]. The osteoclastic resorption of calcium phosphate is a process of 
cell-mediated dissolution in an acidic fluid in the resorption pits [19]. The effect of zinc 
on decreasing the TCP solubility resulted in the same rate of decrease in both the 
dissolution rate and the volume of osteoclastic resorption pits. Thus, the relative 
dissolution rates agreed with the relative pit volumes. However, it should be noted that 
the relative pit volumes (Fig. 7) do not take account of material-mediated differences in 
the total number of pits or osteoclasts between TCP90, 0.5ZnTCP and 1.0 ZnTCP. The 
number of resorbing osteoclasts slightly decreases with an increase in the zinc content 
of TCP in vitro [32]. Thus, the relative dissolution rates multiplied by the total number 
of osteoclasts or resorption pits would be better correlated to the relative amount of 
osteoclastic resorption in vitro.  
 
   A relative dissolution rate may be useful to predict the amount of resorption of 
microporous calcium phosphate having different equilibrium solubility when 
material-mediated differences in biological process are negligible. The effect of Mg on 
decreasing the equilibrium solubility of MgTCP has been substantiated [35, 36]. The 
relative dissolution rate of a MgTCP coincided with the relative V1 and A1 for the 
MgTCP when the denominator of the relative values belonged to another MgTCP. 
However, when the denominator belonged to TCP (TCP60), the relative dissolution rate 
of a MgTCP significantly differed from the relative V1 and A1 for the MgTCP. The 
discrepancy when the denominator belongs to TCP arises from differences in the 
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material-mediated biological process between TCP and MgTCP, as was tentatively 
shown by the increased number of osteoclasts around the MgTCP implants compared 
with TCP implants (Fig. 9). As a result, the relative V1 and A1 for the MgTCP compared 
with TCP resulted from two different effects of Mg incorporated in the TCP lattice: the 
effect of Mg on increasing the resorption of TCP and the effect of Mg on decreasing the 
equilibrium solubility of TCP. The former effect of Mg on the resorption has some link 
with the dose-dependent effects of Mg on the differentiation and function of osteoclasts 
and macrophages [37, 38]. Thus, the relative dissolution rate may be useful when 
material-mediated differences in biological process are negligible. Note that the present 
study demonstrates that a small amount of Mg incorporated in the TCP lattice increases 
the resorption of TCP in vivo.  
 
The validity of using the relative dissolution rate for predicting the resorption of 
pure TCP with different porosity remains to be clarified further. In the case of ZnTCP 
and MgTCP, the specimens had the same porosity and different equilibrium solubility 
while, in the case of pure TCP, the specimens had the same solubility and different 
porosity. Regarding microporosity of TCP, it is reported that an increase in the 
microporosity of TCP has a greater effect on resorption than an increase in 
macroporosity [3, 39, 40]. These phenomena are qualitatively similar to the effect of 
microporosity and macroporosity on the dissolution rates. However, in the previous 
and present studies, in vivo resorption was quantified by measuring the resorbed area or 
volume histomorphometrically. The measured area or volume such as V1 inherently 
includes that of micropores that existed in the resorbed portion. Thus, the net amount 
of resorbed TCP is not V1 but A1. On the other hand, the difference in A1 was 
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statistically insignificant between microporous TCP60 and TCP70. Thus, it cannot be 
ruled out that the agreement between the relative dissolution rate and relative V1 for 
microporous TCPs was an accidental result that arose from the combined effects of the 
latent micropore volume and some biological factor that maintains a constant calcium 
metabolism. To address the above issue, the quantification of A1. Regarding the 
macroporous TCPs, no in vivo study was carried out in the present study. Although the 
10% difference in macroporosity gave a value of nearly 1.0 for the relative dissolution 
rate, it is yet to be clarified whether the 10% difference in macroporosity gives a value 
of 1.0 for the relative V1 and A1. 
 
  Other limitations of the present study are (i) its uncertain applicability to other 
calcium phosphates and (ii) that the protocol for the dissolution tests needs to be 
improved further. The present dissolution test conditions may not be able to predict the 
in vivo resorption of calcium phosphate ceramics different from those tested in the 
present study. The correlation of dissolution tests and in vivo resorption needs to be 
studied for individual calcium phosphate ceramics. In other words, the assay has to be 
established for every ceramic to be analyzed. In addition, the protocol of dissolution 
tests has to be improved to obtain higher precision and better reproducibility of the 
measured values. Means of improvement include pretreatment of specimens before 
immersion, the method of validation, the way the specimen is held in the solution and 
the way of integration of the effect of particle disintegration [41, 42]. One institute (I) 
reported the reduced wettability of specimens probably due to the natural and 
progressive adsorption of organic hydrophobic moieties in air, which was recovered by 
heat treatment before immersion.  
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5. Conclusion 
An in vitro dissolution test method was proposed to estimate the relative rate of 
resorption of calcium-phosphate-based ceramics. According to this method, calcium 
phosphates were dissolved in a neutral or slightly acidic buffer solution free of calcium 
and phosphate ions. Since the calcium phosphates dissolved linearly over the first 5-180 
min, the relative dissolution rates were calculated without difficulty and compared with 
each other. The results suggest that the measurement of the relative dissolution rate in 
vitro is useful as a standard test procedure to predict relative amounts of resorption for 
calcium-phosphate-based ceramics having different solubility, provided that material 
factors, such as a small amount of Mg doping ions, do not affect biological process, 
such as the density or activity of resorbing cells. Further study is required to clarify 
whether the relative dissolution rate is predictive of relative amounts of resorption for 
calcium-phosphate-based ceramics having the same solubility but different porous 
characteristics. 
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 Table 1  Specimens used in the present study 
 
  
    Mg or Zn  Relative  Macro- or    Length or 
 Specimen Notation  content  density  micro-  Shape  Diameter# thickness Study§ 
  No.  (mol%)  (%) porous  (mm) (mm) 
 
 1  TCP25  0  25.8±0.3  macro  block 5.02±0.03  4.52±0.02  dis. 
 2  TCP35 0  35.1±0.7  macro  block  4.99±0.02  4.52±0.03  dis. 
 3  TCP60  0  63±1  micro  cylinder  2.43±0.03  11.3±0.3  dis. 
 4  TCP70  0  74±1  micro  cylinder  2.44±0.02  11.2±0.2  dis. 
 5  1.0MgTCP  1.0Mg  68±1  micro  cylinder  2.43±0.01  10.8±0.1  dis. 
 6  1.7MgTCP  1.7Mg  64±1  micro  cylinder  2.48±0.01  11.1±0.1  dis. 
 7  3.4MgTCP  3.4Mg  62±1  micro  cylinder  2.45±0.01  11.3±0.3  dis. 
 8  TCP60  0  62±1  micro  cylinder  2.41±0.03 (2.50±0.03)  11.1±0.3  in vivo 
 9  TCP70  0  72±1  micro  cylinder  2.45±0.01 (2.52±0.01)  11.2±0.1  in vivo 
 10  1.0MgTCP  1.0Mg  67±1  micro  cylinder  2.43±0.01 (2.37±0.02)  11.2±0.1  in vivo 
 11  1.7MgTCP  1.7Mg  65±1  micro  cylinder  2.48±0.01 (2.37±0.01)  11.4±0.1  in vivo 
 12  3.4MgTCP  3.4Mg  67±1  micro  cylinder  2.45±0.01 (2.34±0.02)  11.2±0.1  in vivo 
 13  TCP90  0  92±1  micro  disk  13.53±0.02  0.90±0.02  ost. dis. 
 14  0.5ZnTCP  0.5Zn  93±1  micro  disk  13.45±0.02  0.89±0.02  ost. dis. 
 15  1.0ZnTCP  1.0Zn  91±1  micro  disk  13.56±0.02  0.91±0.02  ost. dis. 
 
# Parentheses mean the diameters of the non-resorbable biphasic portion at both ends of the cylinder. 
§ dis., in vivo and ost. indicate dissolution, in vivo and osteoclastic resorption studies, respectively. 
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Table 2  Participating research centers, specimens used and dissolution conditions 
 
 
    Solution    Rotation   Collection of solution 
 Research Specimen    Temp. Time speed of  Method* 
  center & Nos.§  Buff.¶ pH  Vol. or  ( ºC)  (min) stirring   Interval Vol. Replen- 
  conditions#    weight    bar (rpm)   (min) (mL) ishment  
            (mL) 
 
 A-1  3-7  Ph  4.0   35mL  25±2  5  430-450  ICP  5  1  1 
 A-2  3-7  Ph  4.0  35mL  25±2  30  430-450  ICP  5  1  1 
 A-3  3-7  Ac  5.5  35mL 25±2  180 430-450 Elect. 
 A-4  1-7  Ac  5.5  35mL  25±2 30 430-450 Elect. 
 A-5  3, 4  Tr  7.3  200mL  37±1  300  200  ICP  60  5  5 
 A-6  3, 4, 7  Tr  7.3  35mL  25±2  30  430±15  Elect. 
 B  3, 4, 7  Ac  5.5  100mL  25±2  30  430±15  Elect. 
 C  3, 4, 7,  Ac  5.5  35mL  25±2  30  430±15  Elect. 
 C 13-15  Ac  5.5  35mL  25±2  30  430±15  Elect. 
 D  3, 4, 7  Ac  5.5  60mL  25±2  30  430±15  Elect. 
 E-1  3, 4, 7  Ac  5.5  60mL  25±2  30  430±15  Elect. 
 E-2  3, 4, 7  Tr  7.3  60mL  25±2  30  430±15  Elect.   
 F  3, 7   Ac  5.5  80mL  26-32  30  430±15  Elect.  
 G  1-4, 7  Ph  4.0  70mL  25±1  30  380  Elect.  
 H-1  3, 4, 7  Ph  4.0  60mL  25±2  30  417-420  AAS  5  1  1 
 H-2  1,2  Ph  4.0 40, 35mL  25±2  30, 18  346-348  AAS  5, 3  1  1 
 I  1-4, 7  Ac  5.5  100g  25±2  30  300  ICP-MS  5  1  0 
 
# The letters indicate the individual research centers while the numbers indicate dissolution 
conditions in the center. 
§ See Table 1. 
¶ Ph, Ac and Tr indicate 0.05 M potassium hydrogen phthalate, 0.08 M acetic acid-sodium acetate 
and 0.05 M Tris-HCl buffers, respectively. 
* “Elect.” indicates measurement using a calcium-ion-selective electrode.    
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Figure 1  Rugged external form of TCP60 (Specimen 8) showing resorption in the 
implantation period of 4 weeks. 
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Figure 2  Dissolution curves for microporous TCP60 (Specimen 3) at pH 5.5 measured 
in different research centers and under different conditions. The plots are presented as 
mean±SD. The number of specimens was 4 or 5. 
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Figure 3  Relative dissolution rates, relative apparent resorbed volume (V1) and relative 
net resorbed amount (A1) for microporous TCP70 (Specimens 4 and 9) compared with 
TCP60 (Specimens 3 and 8). The data are presented as mean±SD. The number of 
samples was 3, 4, 5 or 8 in the dissolution tests. The numbers of samples were 10 for the 
relative V1 and A1.   
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Figure 4  Relative dissolution rates for macroporous TCP25 and TCP35  (Specimens 
1 and 2) compared with TCP60 (Specimen 3) and TCP25. The data are presented as 
mean±SD. The number of samples was 5 or 8.  
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Figure 5  Relative dissolution rates, relative apparent resorbed volume (V1) and relative 
net resorbed amount (A1) for microporous 1.7MgTCP (Specimens 6 and 11) and 
3.4MgTCP (Specimens 7 and 12) compared with 1.0MgTCP (Specimens 5 and 10). The 
data are presented as mean±SD. The number of samples was 5 in the dissolution tests. 
The number of samples was 9 for 1.7MgTCP and 10 for 3.4MgTCP in the in vivo tests. 
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Figure 6 Relative dissolution rates, relative apparent resorbed volume (V1) and relative net resorbed 
amount (A1) for microporous 1.0MgTCP (Specimens 5 and 10), 1.7MgTCP (Specimens 6 and 11) and 
3.4MgTCP (Specimens 7 and 12) compared with microporous TCP60 (Specimens 3 and 8). The data are 
presented as mean±SD. The number of samples was 4, 5 or 8 in the dissolution tests. The number of 
samples was 8 for 1.0MgTCP , 9 for 1.7MgTCP and 10 for 3.4MgTCP in the in vivo tests. 
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Figure 7  Relative pit volumes and relative dissolution rates for 0.5ZnTCP (Specimen 
14) and 1.0ZnTCP (Specimen 15) compared with TCP90 (Specimen 13). The data are 
presented as mean±SD. The number of resorption pits was 120, which were randomly 
selected from four disks with 30 pits per disk. The number of disks was 10 in the 
dissolution tests.   
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Figure 8  Apparent resorbed volume (V1) of microporous TCP and MgTCP (Specimens 
8-12). The data are presented as mean±SD. The number of samples was 8 for 
1.0MgTCP, 9 for TCP60 and 1.7MgTCP, and 10 for TCP70 and 3.4MgTCP. 
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Figure 9 Numbers of TRAP-positive cells around TCP and MgTCP implants (A) and 
histological sections showing TRAP-positive cells around TCP60, 1.7MgTCP and 
3.4MgTCP implants (B). “b” indicates bone. The data are presented as mean±SD. The 
mean and SD for each group are those for the 6-16 microscopic images from one rabbit. 
